Hydrogen Sulfide: A Gaseous Mediator and Its Key Role in Programmed Cell Death, Oxidative Stress, Inflammation and Pulmonary Disease

• Main Authors: Zhixing Zhu (Author), Xihua Lian (Author), Madhav Bhatia (Author)
• Format: Book
• Published: MDPI AG, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 10.3390/antiox11112162; 2076-3921
• Keywords: hydrogen sulfide; gaseous mediator; metabolism; programmed cell death; oxidative stress; inflammation; Therapeutics. Pharmacology; RM1-950
• Source: Antioxidants, Vol 11, Iss 11, p 2162 (2022)

Hydrogen sulfide (H₂S) has been acknowledged as a novel gaseous mediator. The metabolism of H₂S in mammals is tightly controlled and is mainly achieved by many physiological reactions catalyzed by a suite of enzymes. Although the precise actions of H₂S in regulating programmed cell death, oxidative stress and inflammation are yet to be fully understood, it is becoming increasingly clear that H₂S is extensively involved in these crucial processes. Since programmed cell death, oxidative stress and inflammation have been demonstrated as three important mechanisms participating in the pathogenesis of various pulmonary diseases, it can be inferred that aberrant H₂S metabolism also functions as a critical contributor to pulmonary diseases, which has also been extensively investigated. In the meantime, substantial attention has been paid to developing therapeutic approaches targeting H₂S for pulmonary diseases. In this review, we summarize the cutting-edge knowledge on the metabolism of H₂S and the relevance of H₂S to programmed cell death, oxidative stress and inflammation. We also provide an update on the crucial roles played by H₂S in the pathogenesis of several pulmonary diseases. Finally, we discuss the perspective on targeting H₂S metabolism in the treatment of pulmonary diseases.